A Comparison of Randomization Methods for Multi-Arm Clinical Trials

References

• Atkinson, A. C. (2002), “The Comparison of Designs for Sequential Clinical Trials with Covariate Information,” Journal of the Royal Statistical Society, Series A, 165, 349–373. DOI: 10.1111/1467-985X.00564.
   Google Scholar
• Baldi Antognini, A., and Zagoraiou, M. (2011), “The Covariate-Adaptive Biased Coin Design for Balancing Clinical Trials in the Presence of Prognostic Factors,” Biometrika, 98, 519–535. DOI: 10.1093/biomet/asr021.
   Web of Science ®Google Scholar
• Berger, V. W., Bejleri, K., and Agnor, R. (2016), “Comparing MTI Randomization Procedures to Block Randomization,” Statistics in Medicine, 35, 685–694. DOI: 10.1002/sim.6637.
   PubMed Web of Science ®Google Scholar
• Berger, V. W., Bour, L. J., Carter, K., Chipman, J. J., Everett, C. C., Heussen, N., Hewitt, C., Hilgers, R. D., Luo, Y. A., Renteria, J., Ryeznik, Y., Sverdlov, O., and Uschner, D. (2021), “A Roadmap to Using Randomization in Clinical Trials,” BMC Medical Research Methodology, 21, 168. DOI: 10.1186/s12874-021-01303-z.
   PubMed Web of Science ®Google Scholar
• Berger, V. W., Ivanova, A., and Knoll, M. D. (2003), “Minimizing Predictability While Retaining Balance through the Use of Less Restrictive Randomization Procedures,” Statistics in Medicine, 22, 3017–3028. DOI: 10.1002/sim.1538.
   PubMed Web of Science ®Google Scholar
• Burant, C. F., Viswanathan, P., Marcinak, J., Cao, C., Vakilynejad, M., Xie, B., and Leifke, E. (2012), “TAK-875 versus Placebo or Glimepiride in Type 2 Diabetes Mellitus: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial,” The Lancet, 379, 1403–1411. DOI: 10.1016/S0140-6736(11)61879-5.
   PubMed Web of Science ®Google Scholar
• Chen, Y. P. (1999), “Biased Coin Design with Imbalance Tolerance,” Communications in Statistics. Part C: Stochastic Models, 15, 953–975. DOI: 10.1080/15326349908807570.
   Google Scholar
• Diacon, A. H., Dawson, R., von Groote-Bidlingmaier, F., Symons, G., Venter, A., Donald, P. R., van Niekerk, C., Everitt, D., Winter, H., Becker, P., Mendel, C. M., and Spigelman, M. K. (2012), “14-day Bactericidal Activity of PA-824, Bedaquiline, Pyrazinamide, and Moxifl Oxacin Combinations: A Randomised Trial,” The Lancet, 380, 986–993. DOI: 10.1016/S0140-6736(12)61080-0.
   PubMed Web of Science ®Google Scholar
• Hu, F., Hu, Y., Ma, Z., and Rosenberger, W. F. (2014), “Adaptive Randomization for Balancing over Covariates,” WIREs Computational Statistics, 6, 288–303. DOI: 10.1002/wics.1309.
   Google Scholar
• Jin, M., Polis, A., and Hartzel, J. (2021), “Algorithms for Minimization Randomization and the Implementation with an R Package,” Communications in Statistics - Simulation and Computation, 50, 3077–3087. DOI: 10.1080/03610918.2019.1619765.
   Web of Science ®Google Scholar
• Kernan, W. N., Viscoli, C. M., Makuch, R. W., Brass, L. M., and Horwitz, R. I. (1999), “Stratified Randomization for Clinical Trials,” Journal of Clinical Epidemiology, 52, 19–26. DOI: 10.1016/S0895-4356(98)00138-3.
   PubMed Web of Science ®Google Scholar
• Kuznetsova, O. M., and Tymofyeyev, Y. (2012), “Preserving the Allocation Ratio at Every Allocation with Biased Coin Randomization and Minimization in Studies with Unequal Allocation,” Statistics in Medicine, 31, 701–723. DOI: 10.1002/sim.4447.
   PubMed Web of Science ®Google Scholar
• Liu, Y., and Hu, F. (2022), “Balancing Unobserved Covariates with Covariate-Adaptive Randomized Experiments,” Journal of the American Statistical Association, 117, 875–886. DOI: 10.1080/01621459.2020.1825450.
   Web of Science ®Google Scholar
• Ma, Z., and Hu, F. (2013), “Balancing Continuous Covariates Based on Kernel Densities,” Contemporary Clinical Trials, 34, 262–269. DOI: 10.1016/j.cct.2012.12.004.
   PubMed Web of Science ®Google Scholar
• Matthews, J. N. (2006), Introduction to Randomized Controlled Clinical Trials, London: Chapman and Hall/CRC.
   Google Scholar
• Matts, J. P., and Lachin, J. M. (1988), “Properties of Permuted-Block Randomization in Clinical Trials,” Controlled Clinical Trials, 9, 327–344. DOI: 10.1016/0197-2456(88)90047-5.
   PubMedGoogle Scholar
• McPherson, G. C., Campbell, M. K., and Elbourne, D. R. (2012), “Use of Randomisation in Clinical Trials: A Survey of UK Practice,” Trials, 13, 198. DOI: 10.1186/1745-6215-13-198.
   PubMed Web of Science ®Google Scholar
• Park, J. J., Harari, O., Dron, L., Lester, R. T., Thorlund, K., and Mills, E. J. (2020), “An Overview of Platform Trials with a Checklist for Clinical Readers,” Journal of Clinical Epidemiology, 125, 1–8. DOI: 10.1016/j.jclinepi.2020.04.025.
   PubMed Web of Science ®Google Scholar
• Parmar, M. K., Carpenter, J., and Sydes, M. R. (2014), “More Multiarm Randomised Trials of Superiority Are Needed,” The Lancet, 384, 283–284. DOI: 10.1016/S0140-6736(14)61122-3.
   PubMed Web of Science ®Google Scholar
• Pocock, S. J., and Simon, R. (1975), “Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial,” Biometrics, 31, 103. DOI: 10.2307/2529712.
   PubMed Web of Science ®Google Scholar
• Ryeznik, Y., and Sverdlov, O. (2018), “A Comparative Study of Restricted Randomization Procedures for Multiarm Trials with Equal or Unequal Treatment Allocation Ratios,” Statistics in Medicine, 37, 3056–3077. DOI: 10.1002/sim.7817.
   PubMed Web of Science ®Google Scholar
• Soares, J. F., and Wu, C. F. (1983), “Some Restricted Randomization Rules in Sequential Designs,” Communications in Statistics - Theory and Methods, 12, 2017–2034. DOI: 10.1080/03610928308828586.
   Web of Science ®Google Scholar
• Stigsby, B., and Taves, D. R. (2010), “Rank-Minimization for Balanced Assignment of Subjects in Clinical Trials,” Contemporary Clinical Trials, 31, 147–150. DOI: 10.1016/j.cct.2009.12.001.
   PubMed Web of Science ®Google Scholar
• Su, Z. (2011), “Balancing Multiple Baseline Characteristics in Randomized Clinical Trials,” Contemporary Clinical Trials, 32, 547–550. DOI: 10.1016/j.cct.2011.03.004.
   PubMed Web of Science ®Google Scholar
• Sverdlov, O. (2016), “An Overview of Adaptive Randomization Designs in Clinical Trials,” in Modern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects, ed. O. Sverdlov, pp. 3–44, New York: Chapman and Hall/CRC. DOI: 10.1201/b18640.
   Google Scholar
• Taves, D. R. (1962), “Minimization: A New Method of Assigning Patients to Treatment and Control Groups,” Nordisk Medicin, 67, 5–7.
   PubMedGoogle Scholar
• Taves, D. R. (2010), “The Use of Minimization in Clinical Trials,” Contemporary Clinical Trials, 31, 180–184. DOI: 10.1016/j.cct.2009.12.005.
   PubMed Web of Science ®Google Scholar
• Treasure, T., and MacRae, K. D. (1998), “Minimisation: The Platinum Standard for Trials?: Randomisation Doesn’t Guarantee Similarity of Groups; Minimisation Does,” BMJ, 317, 362–363. DOI: 10.1136/bmj.317.7155.362.
   PubMed Web of Science ®Google Scholar
• Wason, J. M. S., Stecher, L., and Mander, A. P. (2014), “Correcting for Multiple-Testing in Multi-Arm Trials: Is It Necessary and Is It Done?” Trials, 15, 364. DOI: 10.1186/1745-6215-15-364.
   PubMed Web of Science ®Google Scholar
• Wei, L. J. (1977), “A Class of Designs for Sequential Clinical Trials,” Journal of the American Statistical Association, 72, 382–386. DOI: 10.1080/01621459.1977.10481005.
   Web of Science ®Google Scholar
• Zhao, W. (2014), “A Better Alternative to Stratified Permuted Block Design for Subject Randomization in Clinical Trials,” Statistics in Medicine, 33, 5239–5248. DOI: 10.1002/sim.6266.
   PubMed Web of Science ®Google Scholar
• Zhao, W., and Weng, Y. (2011), “Block Urn design - A New Randomization Algorithm for Sequential Trials with Two or More Treatments and Balanced or Unbalanced Allocation,” Contemporary Clinical Trials, 32, 953–961. DOI: 10.1016/j.cct.2011.08.004.
   PubMed Web of Science ®Google Scholar